$217.17 $2.52 (1.2%)

02:16 PM EST on 01/22/20

Stryker Corp (NYSE:SYK)

CAPS Rating: 5 out of 5

A medical technology company in orthopaedics products. Its products include implants, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation.

Current Price $217.17 Mkt Cap $80.4B
Open $215.84 P/E Ratio 23.43
Prev. Close $214.65 Div. (Yield) $2.14 (1.0%)
Daily Range $215.53 - $217.86 Volume 111,957
52-Wk Range $206.00 - $217.86 Avg. Daily Vol. 1,424,887


How do you think NYSE:SYK will perform against the market?

Add Stock to CAPS Watchlist

All Players

1,382 Outperform
31 Underperform

All-Star Players

331 Outperform
9 Underperform

Wall Street

2 Outperform
1 Underperform

Top NYSE:SYK Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mikeinmadrid (95.23)
Submitted September 14, 2012

About half of Stryker's revenue comes from reconstructive orthopedic implants, where the firm is a top-tier provider of knees and hips. Demographic trends of obesity and increased life span.Stock price has gone net nowhere since 2004, as eps… More

SophicFool (< 20)
Submitted May 21, 2009

With rising unemployment and subsequent loss of health insurance, people are putting off elective hip and knee surgery which adversely affects Stryker.Also, chief executive Stephen MacMillan recently backed off from giving any long term sales and… More

Recent Community Commentary

Read the most recent pitches from players about SYK.


Member Avatar TMFTypeoh (93.69) Submitted: 1/30/2019 10:21:37 AM : Outperform Start Price: $174.78 NYSE:SYK Score: -1.80

steady as she goes.


Member Avatar rmburkettjr30 (31.08) Submitted: 7/30/2016 9:01:16 PM : Outperform Start Price: $111.32 NYSE:SYK Score: +41.28

This is one of the last few independent implant/medical device companies. They seem to be doing very well for a company that didn't have to join forces with anyone else. My guess is eventually they will be acquired by someone but until then they will continue to outperform.


Member Avatar TurksFan (42.14) Submitted: 9/29/2015 10:27:56 AM : Outperform Start Price: $88.98 NYSE:SYK Score: +67.82

I decided to move off of the energy stocks this week and pick a medical device/equipment/neurovascular innovator, Stryker Corporation (NYSE: SYK). Besides being a homie (headquartered in Michigan), you will likely see it's products in any hospital you visit. Full disclosure, I own Stryker and have for years. However recently, the price declined due to Congressional rabble rousing and the fear of litigation due to implants. It's acquisition strategy has helped it keep its market share. The recent acquisition of Trausin Company maintains its foothold in the China market. Due to the recent volatility of the market, and the avoidance of anything related to China or medical technology, this pick is a let's see what happens pick.


Find the members with the highest scoring picks in SYK.

Score Leader


db74006 (52.44) Score: +377.25

The Score Leader is the player with the highest score across all their picks in SYK.

Member Name Member
Call Time
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. db74006 52.44 3/23/2009 Outperform NS $27.51 +686.16% +321.34% +364.82 0 Comment
Xitopie < 20 4/3/2009 Outperform 5Y $28.71 +653.20% +299.38% +353.81 1 Comment
tpulley 42.37 3/23/2009 Outperform NS $27.80 +678.07% +326.42% +351.65 1 Comment
saaf569 57.99 3/23/2009 Outperform 3Y $27.80 +678.07% +326.42% +351.65 0 Comment
Moreliator 41.25 3/23/2009 Outperform 3Y $28.06 +670.86% +319.29% +351.58 1 Comment
bejeweledfool 50.69 4/6/2009 Outperform 5Y $28.82 +650.48% +302.72% +347.76 0 Comment
MaxPower13 98.34 4/6/2009 Outperform 5Y $28.70 +653.65% +306.62% +347.02 0 Comment
chaddodson 63.46 4/7/2009 Outperform 3Y $28.68 +654.11% +307.81% +346.30 0 Comment
MuhaPSU 98.47 4/7/2009 Outperform 5Y $28.59 +656.39% +311.36% +345.04 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. tacross3 54.08 4/8/2009 Outperform 3Y $28.84 +649.79% +309.16% +340.64 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SYK.